Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1035219-80-7

Post Buying Request

1035219-80-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1035219-80-7 Usage

General Description

2-Bromothiazolo[5,4-c]pyridin-4(5H)-one is a chemical compound with the molecular formula C8H5BrN2OS. It is a heterocyclic compound that contains a thiazole ring fused to a pyridine ring, as well as a bromine atom and a ketone functional group. 2-broMothiazolo[5,4-c]pyridin-4(5H)-one has potential applications in the field of medicinal chemistry, as it may exhibit biological activity. Further research is needed to fully understand its properties and potential uses.

Check Digit Verification of cas no

The CAS Registry Mumber 1035219-80-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,5,2,1 and 9 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1035219-80:
(9*1)+(8*0)+(7*3)+(6*5)+(5*2)+(4*1)+(3*9)+(2*8)+(1*0)=117
117 % 10 = 7
So 1035219-80-7 is a valid CAS Registry Number.

1035219-80-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-bromo-5H-[1,3]thiazolo[5,4-c]pyridin-4-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1035219-80-7 SDS

1035219-80-7Relevant articles and documents

ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF

-

Page/Page column 73, (2021/12/31)

The disclosure relates to compounds that act as allosteric inhibitors of epidermal growth factor receptor (EGFR); pharmaceutical compositions comprising the compounds; and methods of treating or preventing kinase-mediated disorders, including cancer and other proliferation diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1035219-80-7